Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Commentary

  • 1,915 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 14
  • 15
  • 16
  • …
  • 191
  • 192
  • Next →
A role for TMEM63 in the lung
Jaime L. Hook
Jaime L. Hook
Published March 1, 2024
Citation Information: J Clin Invest. 2024;134(5):e178948. https://doi.org/10.1172/JCI178948.
View: Text | PDF

A role for TMEM63 in the lung

  • Text
  • PDF
Abstract

Surfactants are essential for breathing. Although major progress has been made in the past half century toward an understanding of surfactant secretion mechanisms, the identity of the mechanosensor that couples breathing to surfactant secretion has remained elusive. In this issue of the JCI, Chen, Li, and colleagues provide evidence that the mechanosensor is the transmembrane 63 (TMEM63) ion channel. These findings open new avenues for future research into lung mechanobiology.

Authors

Jaime L. Hook

×

NETs unleashed: neutrophil extracellular traps boost chemotherapy against colorectal cancer
Alexandra Mousset, Jean Albrengues
Alexandra Mousset, Jean Albrengues
Published March 1, 2024
Citation Information: J Clin Invest. 2024;134(5):e178344. https://doi.org/10.1172/JCI178344.
View: Text | PDF

NETs unleashed: neutrophil extracellular traps boost chemotherapy against colorectal cancer

  • Text
  • PDF
Abstract

Chemotherapy, which primarily acts on cancer cells, can influence the tumor microenvironment and the recruitment and behavior of stromal cells. In this issue of the JCI, Li et al. explored the potent anticancer effect of the combination of a glutaminase inhibitor (CB-839) and 5-FU against PIK3CA-mutant colorectal cancer tumors. This chemotherapy treatment strongly induced the recruitment of neutrophils that formed neutrophil extracellular traps in cancer, which actively killed cancer cells by inducing apoptosis. This study substantially advances our understanding of the multifaceted role of neutrophils and NETs in the outcome of anticancer treatment.

Authors

Alexandra Mousset, Jean Albrengues

×

Tipping the balance toward transplantation tolerance: in vivo therapy using a mutated IL-2
Geoffrey Camirand, Fadi G. Lakkis
Geoffrey Camirand, Fadi G. Lakkis
Published March 1, 2024
Citation Information: J Clin Invest. 2024;134(5):e178570. https://doi.org/10.1172/JCI178570.
View: Text | PDF

Tipping the balance toward transplantation tolerance: in vivo therapy using a mutated IL-2

  • Text
  • PDF
Abstract

Immune tolerance to allogenic transplanted tissues remains elusive, and therapeutics promoting CD4+FOXP3+ Tregs are required to achieve this ultimate goal. In this issue of the JCI, Efe and colleagues engineered an Fc domain fused to a human mutein IL-2 (mIL-2–Fc) bearing mutations that confer preferential binding to the high-affinity IL-2 receptor expressed on Tregs. In vivo mIL-2–Fc therapy effectively heightened mouse, monkey, and human Treg numbers, promoted tolerance to minor antigen mismatched skin grafts in mice, and synergized with immunosuppressive drugs used in the clinic. These findings warrant clinical trials that assess the efficacy of mIL-2–Fc in transplantation.

Authors

Geoffrey Camirand, Fadi G. Lakkis

×

Lipid droplets in the endothelium: The missing link between metabolic syndrome and cardiovascular disease?
Iris Z. Jaffe, S. Ananth Karumanchi
Iris Z. Jaffe, S. Ananth Karumanchi
Published February 15, 2024
Citation Information: J Clin Invest. 2024;134(4):e176347. https://doi.org/10.1172/JCI176347.
View: Text | PDF

Lipid droplets in the endothelium: The missing link between metabolic syndrome and cardiovascular disease?

  • Text
  • PDF
Abstract

The physiology of lipid droplets (LDs) has been most extensively characterized in adipocytes, but LDs also accumulate in endothelial cells lining blood vessels in response to changing levels of triglycerides. In recent issues of the JCI, two independent papers highlight a direct role of endothelial LDs in the genesis of hypertension and atherosclerosis in rodent models. Kim et al. demonstrated that accumulation of LDs in the endothelium leads to hypertension, impairs endothelial function, and accelerates atherosclerosis. Boutagy, Gamez-Mendez, et al. knocked out Atgl in the endothelium and confirmed triglyceride accumulation in endothelial cells that was associated with reduced NO synthesis and impaired endothelial-dependent vasodilation. These data suggest that enhancing triglyceride breakdown in the endothelium could provide a treatment target for patients with metabolic syndrome.

Authors

Iris Z. Jaffe, S. Ananth Karumanchi

×

Yoda1 opens the lymphatic path for craniosynostosis therapy
Aleksanteri Aspelund, Kari Alitalo
Aleksanteri Aspelund, Kari Alitalo
Published February 15, 2024
Citation Information: J Clin Invest. 2024;134(4):e176858. https://doi.org/10.1172/JCI176858.
View: Text | PDF

Yoda1 opens the lymphatic path for craniosynostosis therapy

  • Text
  • PDF
Abstract

The rediscovery of meningeal lymphatic vessels (MLVs) has sparked research interest in their function in numerous neurological pathologies. Craniosynostosis (CS) is caused by a premature fusion of cranial sutures during development. In this issue of the JCI, Matrongolo and colleagues show that Twist1-haploinsufficient mice that develop CS exhibit raised intracranial pressure, diminished cerebrospinal fluid (CSF) outflow, and impaired paravascular CSF-brain flow; all features that were associated with MLV defects and exacerbated pathology in mouse models of Alzheimer’s disease. Activation of the mechanosensor Piezo1 with Yoda1 restored MLV function and CSF perfusion in CS models and in aged mice, opening an avenue for further development of therapeutics.

Authors

Aleksanteri Aspelund, Kari Alitalo

×

NKT cells in the antitumor response: the β version?
Mitchell Kronenberg, Isaac Engel
Mitchell Kronenberg, Isaac Engel
Published February 15, 2024
Citation Information: J Clin Invest. 2024;134(4):e177663. https://doi.org/10.1172/JCI177663.
View: Text | PDF

NKT cells in the antitumor response: the β version?

  • Text
  • PDF
Abstract

NKT cells recognize glycolipids presented by CD1d-expressing antigen-presenting cells (APCs) and include type I NKT cells with antitumor function and type II NKT cells, which have been reported to suppress the antitumor response. Some type II NKT cells recognize sulfatide, a glycosphingolipid with a sulfate modification of the sugar. Type I NKT cells recognize different glycosphingolipids. In this issue of the JCI, Nishio and colleagues showed that APCs could process sulfatide antigens, analogous to protein processing for peptide-reactive T cells. Antigen processing in lysosomes removed sulfate to generate a glycosphingolipid that stimulated type I NKT cells and thereby turned an antigen with no antitumor activity into one that not only stimulated type I NKT cells but also stimulated antitumor responses. These findings may extend to the development of glycolipid antigens that could stimulate anticancer responses via antigen processing by APCs.

Authors

Mitchell Kronenberg, Isaac Engel

×

Reduced Bik expression drives low-grade airway inflammation and increased risk for COPD in females
Irina Petrache, David W.H. Riches
Irina Petrache, David W.H. Riches
Published February 15, 2024
Citation Information: J Clin Invest. 2024;134(4):e177753. https://doi.org/10.1172/JCI177753.
View: Text | PDF

Reduced Bik expression drives low-grade airway inflammation and increased risk for COPD in females

  • Text
  • PDF
Abstract

Chronic low-grade inflammation is increasingly recognized as a subtle yet potent risk factor for a multitude of age-related disorders, including respiratory diseases, cardiovascular conditions, metabolic syndromes, autoimmunity, and cancer. In this issue of the JCI, Mebratu, Jones, and colleagues shed new light on the mechanisms that promote low-grade airway inflammation and how this contributes to the development of chronic obstructive pulmonary disease (COPD). Their finding that Bik deficiency leads to spontaneous emphysema in female mice, but not in males, marks a notable advancement in our understanding of how inflammatory processes can diverge based on biological sex. This finding is of clinical relevance, given the vulnerability of women to developing COPD.

Authors

Irina Petrache, David W.H. Riches

×

Targeting de novo lipogenesis to mitigate kidney disease
Haikuo Li, Benjamin D. Humphreys
Haikuo Li, Benjamin D. Humphreys
Published February 15, 2024
Citation Information: J Clin Invest. 2024;134(4):e178125. https://doi.org/10.1172/JCI178125.
View: Text | PDF

Targeting de novo lipogenesis to mitigate kidney disease

  • Text
  • PDF
Abstract

Ten percent of the population worldwide suffers from chronic kidney disease (CKD), but the mechanisms driving CKD pathology are incompletely understood. While dysregulated lipid metabolism is one hallmark of CKD, the pathogenesis of cellular lipid accumulation remains unclear. In this issue of the JCI, Mukhi et al. Identify acyl-CoA synthetase short-chain family 2 (ACSS2) as a disease risk gene and demonstrate a role for ACSS2 in de novo lipogenesis (DNL). Notably, genetic or pharmacological inhibition of DNL protected against kidney disease progression in mice. These findings warrant evaluation of DNL inhibition with respect to efficacy and safety in people with CKD.

Authors

Haikuo Li, Benjamin D. Humphreys

×

AEP promotes aberrant RNA splicing through DDX3X cleavage in solid tumors
Yadong Xie, … , Haohao Zhang, Xinyang Song
Yadong Xie, … , Haohao Zhang, Xinyang Song
Published February 1, 2024
Citation Information: J Clin Invest. 2024;134(3):e177609. https://doi.org/10.1172/JCI177609.
View: Text | PDF

AEP promotes aberrant RNA splicing through DDX3X cleavage in solid tumors

  • Text
  • PDF
Abstract

Aberrant alternative splicing (AS) events have been identified in a variety of cancers. Although somatic mutations of splicing factors and dysregulation of RNA-binding proteins (RBPs) have been linked to AS and tumor malignancy, it remains unclear how upstream mechanisms contribute to cancer development via alternative gene splicing. In this issue of the JCI, Wenrui Zhang and colleagues identified the role of asparagine endopeptidase (AEP), an intracellular cysteine endopeptidase, in promoting solid tumor–associated RNA splicing. The authors demonstrated that tumor environmental factors such as oxygen and nutrient deprivation induce the activity of AEP in a HIF1A-dependent manner. The activated AEP, in turn, cleaves an RNA helicase DDX3X to promote its nuclear retention. The authors further showed that this DDX3X nuclear fraction engages with splicing machinery to induce AS events in several cancer cells. These findings suggest that targeting an AEP-dependent aberrant RNA splicing cascade may facilitate therapeutics for solid tumors.

Authors

Yadong Xie, Haohao Zhang, Xinyang Song

×

Biofilm-derived oxylipin 10-HOME mediated immune response in women with breast implants
Tyler M. Bauer, Katherine A. Gallagher
Tyler M. Bauer, Katherine A. Gallagher
Published February 1, 2024
Citation Information: J Clin Invest. 2024;134(3):e176547. https://doi.org/10.1172/JCI176547.
View: Text | PDF

Biofilm-derived oxylipin 10-HOME mediated immune response in women with breast implants

  • Text
  • PDF
Abstract

Breast implant illness (BII) is a poorly understood disease in which patients develop symptoms typical of autoimmune conditions following breast implantation. There is no known underlying cause, and patients often resort to breast implant removal and capsulectomy to alleviate symptoms. In this issue of the JCI, Khan and colleagues examined 86 breast explants from patients that reported BII symptoms and 55 control explants. The BII group showed a disproportionally high degree of biofilm, which was associated with oxylipin (10-HOME) on the implant surfaces. Injections of 10-HOME in the mammary fat pad of a murine model recapitulated BII symptoms and increased Th1 cell populations. Notably, macrophages in the periprosthetic tissue from BII patients were more likely to exhibit a proinflammatory phenotype, and naive T cells exposed to 10-HOME caused naive macrophages to differentiate to a proinflammatory phenotype. This work provides a pathophysiologic mechanism for a currently understudied and poorly characterized disease.

Authors

Tyler M. Bauer, Katherine A. Gallagher

×
  • ← Previous
  • 1
  • 2
  • …
  • 14
  • 15
  • 16
  • …
  • 191
  • 192
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts